Cheap 66-Cent pill could be Game-Changer for sleep apnea sufferers
NCT ID NCT05804084
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests a low-cost pill called acetazolamide for people with moderate to severe sleep apnea who cannot tolerate a CPAP mask. Sixty adults will receive either the drug or a placebo for 4 weeks each, and researchers will measure sleep quality, memory, and quality of life. The goal is to see if this well-known, once-daily medication can offer a simple drug therapy option for millions of untreated patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UC San Diego; Altman Clinical and Translational Research Institute Building
RECRUITINGLa Jolla, California, 92121, United States
Contact
Conditions
Explore the condition pages connected to this study.